Elsevier

The Spine Journal

Volume 22, Issue 12, December 2022, Pages 1934-1943
The Spine Journal

Clinical Study
Changes of the microbiological spectrum and antibiotic resistance pattern in postoperative spinal implant infections with multiple culture-positive revision surgeries

https://doi.org/10.1016/j.spinee.2022.07.086Get rights and content

Abstract

BACKGROUND CONTEXT

In severe cases of postoperative spinal implant infections (PSII) multiple revision surgeries may be needed. Little is known if changes in the microbiological spectrum and antibiotic resistance pattern occur between revision surgeries.

PURPOSE

Analysis of the microbiological spectrum and antibiotic resistance pattern in patients with multiple revision surgeries for the treatment of PSII

STUDY DESIGN

Retrospective database analysis.

PATIENT SAMPLE

Between 01/2011 and 12/2018, 103 patients underwent 248 revision surgeries for the treatment of PSII. Twenty patients (19.4%) who underwent multiple revision surgeries for PSII were included in this study.

OUTCOME MEASURES

Microbiological spectrum, antibiotic resistance pattern.

METHODS

A retrospective analysis of a prospectively maintained single center spine infection database was performed with a minimum follow-up of 3 years. Overall, 20 patients (six male/14 female) underwent 82 revisions for PSII (median 3; range 2–12). There were 55 of 82 (67.1%) procedures with a positive microbiological result. Microbiological analysis was performed on tissue and implant sonication fluid. Changes in microbial spectrum and antibiotic resistance pattern between surgeries were evaluated using Chi-Square and Fisher's exact test.

RESULTS

In total, 74 microorganisms (83.3% gram-positive; 10.8% gram-negative) were identified. The most common microorganisms were Staphylococcus epidermidis (18.9%) and Cutibacterium acnes (18.9%). All S. epidermidis identified were methicillin-resistant (MRSE). Overall, there were 15 of 55 (27.3%) polymicrobial infections. The microbiological spectrum changed in 57.1% (20/35) between the revision stages over the entire PSII period. In 42.9% (15/35) the microorganism persisted between the revision surgeries stages. Overall, changes of the antibiotic resistance pattern were seen in 17.4% (8/46) of the detected microorganisms, comparing index revision and all subsequent re-revisions. Moreover, higher resistance rates were found for moxifloxacin and for ciprofloxacin at first re-revision surgery compared with index PSII revision. Resistances against vancomycin increased from 4.5% (1/23) at index PSII revision to 7.7% (2/26) at first re-revision surgery.

CONCLUSIONS

Changes of the microbiological spectrum and the resistance pattern can occur in patients with severe PSII who require multiple revision surgeries. It is important to consider these findings in the antimicrobial treatment of PSII. The microbiological analysis of intraoperative tissue samples should be performed at every revision procedure for PSII.

Introduction

Postoperative spinal implant infections (PSII) after spinal fusion pose significant clinical challenges and can result in high postoperative morbidity, mortality, and increased health care costs [1]. Recent studies demonstrate a higher incidence of PSII in patients who undergo a presumed aseptic revision surgery compared to primary instrumentation [2]. The surgical management of PSII includes surgical debridement-irrigation, antibiotic therapy, and implant retention (DAIR) for early onset infections and implant removal for late-onset infections [3]. In severe cases, single revision surgery may not be sufficient and multiple revisions are needed [4]. Especially, polymicrobial infections are of concern due to limited treatment options and a higher risk of treatment failure [5]. Persistent infections occur due to unsuccessful eradication of the causative microorganisms, which can lead to multidrug resistances due to prolonged administration of antibiotics [6]. There are a number of studies on the microbiological spectrum of patients with PSII that show a wide range of causative pathogens, with Staphylococcus epidermidis and Cutibacterium acnes as the most prevalent microorganisms. Especially, in late-onset infections after instrumented fusion, S. epidermidis seems to be one of the most involved microorganisms [2,7].

In periprosthetic infection (PJI) of the hip and knee joint it was shown that changes of the microbiological profile are common in culture-positive revisions at different revision stages [8,9]. Isolation of different microorganisms at a later septic procedure might be due to eradication of the initially detected microorganism and acquirement of an additional microorganism or due to an undetected polymicrobial infection at first stage procedure. If the same microorganism is detected at later revision procedure it is most likely due to persistence of the initially detected microorganism [10]. However, there is little data on potential changes of the microbiological spectrum and antibiotic resistance pattern in patients who underwent multiple revision surgeries for PSII [6].

Therefore, the aim of this study was to perform a retrospective single center study to analyze the microbiological spectrum and resistance patterns in patients with confirmed PSII after multiple revision surgeries with positive culture results. Furthermore, changes of the microbiological spectrum, distribution of mono- versus polymicrobial infections, and changes of the antimicrobial resistance profile in persistent microorganisms were evaluated.

Section snippets

Materials and methods

After institutional review board approval, a retrospective single-center analysis of all medical records from the in-house PSII infection database was performed. PSII was determined according to the Centers for Disease Control and Prevention (CDC) criteria for SSI [11]. Between January 2011 and December 2018, a total of 1,297 spinal revision surgeries were performed on 1,053 patients. Overall, 248 of 1,297 (19.1%) revision surgeries were performed on 103 of 1,053 (9.8%) patients due to PSII. In

Results

Eighty-two revision surgeries were performed on 20 patients with multiple culture-positive PSII revision surgeries. Intraoperative positive cultures were found in 55 of 82 (67.1%) procedures. The PSII revision surgeries performed were DAIR, implant removal and implant exchange (re-fusion and fusion extension). The median time between index PSII revision and the first re-revision was 1.1 months (range 0.1–74.3) and 4.1 months (range 0.1–23.1) between first re-revision and second re-revisions.

Microbiological spectrum

In total, 250 microbiological cultures were taken intraoperatively and analyzed. A positive microbiological result was seen in 73.2% (183/250). The median number of culture-positive results was three (range 2–8). In 55 multiple culture-positive revision surgeries, 74 microorganisms were detected, displayed in Table 1. There were 28 causative microorganisms detected at index PSII revision surgery, 28 at first re-revision surgery and 18 at all subsequent re-revision surgeries. We identified 25

Discussion

In this study, we showed that changes of the microbiological spectrum are very common in patients who require multiple surgeries for the treatment of PSII. We identified changes of the spectrum in more than half of our patients over the entire PSII period. The changes reported in this study are lower compared to studies describing multiple culture-positive implant related infections [9,15]. Frank et al. showed that changes of the microbiological profile between different stages of a 2-stage

Conclusion

To ensure appropriate antibiotic treatment, analysis of the microbiological spectrum, its changes over time, and alterations of the resistance profile in patients with persistent microorganisms is essential. The results presented in this study showed that there are relevant changes of the distribution of microorganisms in patients with multiple culture-positive revisions. In persistent pathogens, the antibiotic resistance profile showed changes over the PSII period. It is important to consider

Declaration of Competing Interest

The authors declared that there are no conflicts of interest. There was no financial support for this study.

Acknowledgment

We thank Christina Schober, MA for her involvement and help in the data collection for this document.

References (48)

  • C Abdul-JabbarAmir et al.

    Surgical site infections in spine surgery: identification of microbiologic and surgical characteristics in 239 cases

    Spine (Phila Pa 1976)

    (2013)
  • D Yin et al.

    Management of late-onset deep surgical site infection after instrumented spinal surgery

    BMC Surg

    (2018)
  • H Wille et al.

    Efficacy of debridement, antibiotic therapy and implant retention within three months during postoperative instrumented spine infections

    Infect Dis (Auckl)

    (2017)
  • L Tian et al.

    Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017)

    Antimicrob Resist Infect Control

    (2019)
  • J Zhou et al.

    Incidence of surgical site infection after spine surgery: a systematic review and meta-analysis

    Spine (Phila Pa 1976)

    (2020)
  • DMC Janssen et al.

    A retrospective analysis of deep surgical site infection treatment after instrumented spinal fusion with the use of supplementary local antibiotic carriers

    J Bone Jt Infect

    (2018)
  • Y Mu et al.

    Improving risk-adjusted measures of surgical site infection for the national healthcare safely network

    Infect Control Hosp Epidemiol

    (2011)
  • CDC, Ncezid, DHQP. 2019 NHSN Surgical Site Infection (SSI) Checklist Surgical Site Infection (SSI) documentation review...
  • The European Committee on Antimicrobial Susceptibility Testing....
  • K Yamada et al.

    Clinical characteristics of methicillin-resistant coagulase-negative staphylococcal bacteremia in a tertiary hospital

    Intern Med

    (2017)
  • M Faschingbauer et al.

    Outcome of irrigation and debridement after failed two-stage reimplantation for periprosthetic joint infection

    Biomed Res Int

    (2018)
  • A-K Hickmann et al.

    Management and outcome of spinal implant-associated surgical site infections in patients with posterior instrumentation: analysis of 176 cases

    Eur Spine J [Internet]

    (2021)
  • S Simon et al.

    Analysis of failed two-stage procedures with resection arthroplasty as the first stage in periprosthetic hip joint infections

    J Clin Med

    (2021)
  • HW Dennis Hey et al.

    Spinal implants can be inserted in patients with deep spine infection

    Spine (Phila Pa 1976)

    (2017)
  • Cited by (2)

    FDA device/drug status: Not applicable.

    Author disclosure: JAM: Nothing to disclose. BJHF: Nothing to disclose. SGH: Nothing to disclose. LFP: Nothing to disclose. SS: Nothing to disclose. PK: Nothing to disclose. JGH: Research Support (Investigator Salary, Staff/Materials)^: mageBiopsylab (E, Paid directly to institution). Level E: $50,001 to $100,000.

    View full text